BACKGROUND:Pharmacist- or nurse-led team care decreases patient blood pressure (BP) and cardiovascular disease (CVD) risk. PURPOSE: To evaluate whether a Web-based dietitian-led (WD) team care intervention was feasible and resulted in decreased BP, CVD risk, and weight compared to usual care (UC). METHODS: Electronic health record (EHR) data identified patients aged 30-69 years with BMI >26, elevated BP, and 10%-25% 10-year Framingham CVD risk who were registered patient website users. Patients with uncontrolled BP at screening were randomized to UC or WD, which included a home BP monitor, scale, and dietitian team care. WD participants had a single in-person dietitian visit to obtain baseline information and create a plan to reduce CVD risk. Planned follow-up occurred via secure messaging to report BP, weight, and fruit and vegetable intake and receive ongoing feedback. If needed, dietitians encouraged patients and their physicians to intensify antihypertensive and lipid-lowering medications. Primary outcomes were change in systolic BP and weight loss ≥4 kg at 6 months. Feasibility outcomes included intervention utilization and satisfaction. RESULTS:Between 2010 and 2011, a total of 90 of 101 participants completed 6-month follow-ups. The WD group had higher rates of secure messaging utilization and patient satisfaction. The WD group lost significantly more weight than the UC group (adjusted net difference=-3.2 kg, 95% CI=-5.0, -1.5, p<0.001) and was more likely to lose ≥4 kg (adjusted relative risk [RRadj]=2.96, 95% CI=1.16, 7.53). BP control and CVD risk reduction were greater in WD than UC, but differences were not statistically significant. CONCLUSIONS: WD intervention was feasible and resulted in decreased weight, BP, and CVD risk. A larger trial is justified. TRIAL REGISTRATION NUMBER: Trial Registration Number: NCT01077388.
RCT Entities:
BACKGROUND: Pharmacist- or nurse-led team care decreases patient blood pressure (BP) and cardiovascular disease (CVD) risk. PURPOSE: To evaluate whether a Web-based dietitian-led (WD) team care intervention was feasible and resulted in decreased BP, CVD risk, and weight compared to usual care (UC). METHODS: Electronic health record (EHR) data identified patients aged 30-69 years with BMI >26, elevated BP, and 10%-25% 10-year Framingham CVD risk who were registered patient website users. Patients with uncontrolled BP at screening were randomized to UC or WD, which included a home BP monitor, scale, and dietitian team care. WDparticipants had a single in-person dietitian visit to obtain baseline information and create a plan to reduce CVD risk. Planned follow-up occurred via secure messaging to report BP, weight, and fruit and vegetable intake and receive ongoing feedback. If needed, dietitians encouraged patients and their physicians to intensify antihypertensive and lipid-lowering medications. Primary outcomes were change in systolic BP and weight loss ≥4 kg at 6 months. Feasibility outcomes included intervention utilization and satisfaction. RESULTS: Between 2010 and 2011, a total of 90 of 101 participants completed 6-month follow-ups. The WD group had higher rates of secure messaging utilization and patient satisfaction. The WD group lost significantly more weight than the UC group (adjusted net difference=-3.2 kg, 95% CI=-5.0, -1.5, p<0.001) and was more likely to lose ≥4 kg (adjusted relative risk [RRadj]=2.96, 95% CI=1.16, 7.53). BP control and CVD risk reduction were greater in WD than UC, but differences were not statistically significant. CONCLUSIONS:WD intervention was feasible and resulted in decreased weight, BP, and CVD risk. A larger trial is justified. TRIAL REGISTRATION NUMBER: Trial Registration Number: NCT01077388.
Authors: Andrew J Karter; Melissa M Parker; Howard H Moffet; Ameena T Ahmed; Julie A Schmittdiel; Joe V Selby Journal: Health Serv Res Date: 2009-06-03 Impact factor: 3.402
Authors: F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245
Authors: Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young Journal: JAMA Date: 2003 Apr 23-30 Impact factor: 56.272
Authors: V J Stevens; E Obarzanek; N R Cook; I M Lee; L J Appel; D Smith West; N C Milas; M Mattfeldt-Beman; L Belden; C Bragg; M Millstone; J Raczynski; A Brewer; B Singh; J Cohen Journal: Ann Intern Med Date: 2001-01-02 Impact factor: 25.391
Authors: J D Neaton; R H Grimm; R J Prineas; J Stamler; G A Grandits; P J Elmer; J A Cutler; J M Flack; J A Schoenberger; R McDonald Journal: JAMA Date: 1993-08-11 Impact factor: 56.272
Authors: Kunal N Karmali; Stephen D Persell; Pablo Perel; Donald M Lloyd-Jones; Mark A Berendsen; Mark D Huffman Journal: Cochrane Database Syst Rev Date: 2017-03-14
Authors: Cathrien R L Beishuizen; Blossom C M Stephan; Willem A van Gool; Carol Brayne; Ron J G Peters; Sandrine Andrieu; Miia Kivipelto; Hilkka Soininen; Wim B Busschers; Eric P Moll van Charante; Edo Richard Journal: J Med Internet Res Date: 2016-03-11 Impact factor: 5.428
Authors: Molly M Warner; Jaimon T Kelly; Dianne P Reidlinger; Tammy C Hoffmann; Katrina L Campbell Journal: J Med Internet Res Date: 2017-12-11 Impact factor: 5.428
Authors: Katherine L Tucker; James P Sheppard; Richard Stevens; Hayden B Bosworth; Alfred Bove; Emma P Bray; Kenneth Earle; Johnson George; Marshall Godwin; Beverly B Green; Paul Hebert; F D Richard Hobbs; Ilkka Kantola; Sally M Kerry; Alfonso Leiva; David J Magid; Jonathan Mant; Karen L Margolis; Brian McKinstry; Mary Ann McLaughlin; Stefano Omboni; Olugbenga Ogedegbe; Gianfranco Parati; Nashat Qamar; Bahman P Tabaei; Juha Varis; Willem J Verberk; Bonnie J Wakefield; Richard J McManus Journal: PLoS Med Date: 2017-09-19 Impact factor: 11.069
Authors: J P Sheppard; K L Tucker; W J Davison; R Stevens; W Aekplakorn; H B Bosworth; A Bove; K Earle; M Godwin; B B Green; P Hebert; C Heneghan; N Hill; F D R Hobbs; I Kantola; S M Kerry; A Leiva; D J Magid; J Mant; K L Margolis; B McKinstry; M A McLaughlin; K McNamara; S Omboni; O Ogedegbe; G Parati; J Varis; W J Verberk; B J Wakefield; R J McManus Journal: Am J Hypertens Date: 2020-03-13 Impact factor: 2.689